Article Sidebar

Submitted
31 October 2017
Accepted
31 October 2017
Published
3 November 2017
Download
PDF
Statistic
Read Counter : 2724 Download : 1889

Main Article Content

Abstract

Thiamine, also called vitamin B1, is a water soluble vitamin that is involved in the formation of ATP in cells. The active metabolite of thiamine is a co-enzyme thiamine pyrophosphate (TPP) that plays an active role in carbohydrate metabolism and the formation of amino acid binding conjugates. Directly, thiamine may increase energy production in heart muscle cells through such mechanism, whereas in conditions of heart failure, a decrease in the contractility of  heart muscle may be found. Therefore, thiamine supplementation is needed in stage II heart failure patients due to long-term use of furosemide that triggers the thiamine deficiency condition. Thiamine supplementation here is enabled to increase heart cells contractility which may ultimately increase the ejection fraction value of the heart muscle as a parameter of heart work efficiency measurement. The objective of this study was to evaluate the effect of thiamine administration as a therapeutic supplement in stage II of heart failure patients on the ejection fraction rate changes in pre and post thiamine supplement therapy for 28 days. The study was conducted using Cross Sectional Prospective Observational Analysis method between April and August 2016 in male patients with NYHA II heart failure who received furosemide therapy meeting the inclusion criteria at Heart Clinic Jemursari Islamic Hospital, Surabaya. Patients who fulfilled the inclusion and exclusion criteria in this study were 32 patients, 16 control patients and 16 treatment group patients between the ages of 35-75 years. During this study, after supplementation of thiamine 300 mg/day, 16 patients in the treatment group experienced an increase in ejection fraction rate (13.5%). The result of paired t test p=0.000 (p<α; α=0,05) showed significant difference between ejection fraction rate of pre and post thiamin supplementation. This study concluded that thiamine supplement therapy of 300 mg/day could increase the ejection fraction rate in patients of stage II heart failure.

Keywords

thiamine deficiency supplementation diuretics ejection fraction

Article Details

License

  • Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:

    Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

    NonCommercial ” You may not use the material for commercial purposes.

    ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

    No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

    You  are free to :

    Share ” copy and redistribute the material in any medium or format.

    Adapt ” remix, transform, and build upon the material.

How to Cite
Jikrona, R., Suharjono, S., & Ahmad, A. (2017). THIAMINE SUPPLEMENT THERAPY IMPROVES EJECTION FRACTION VALUE IN STAGE II HEART FAILURE PATIENTS. Folia Medica Indonesiana, 53(2), 139–143. https://doi.org/10.20473/fmi.v53i2.6358
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Brunton LL, Chabner BA, Knollmann, BC (2011). Goodman and gilman's the pharmacological basis of therapeutics. 12th ed. New York, McGraw-Hill
  2. Chavey WE (2006). Heart failure–systolic disfunction, guide for clin. Care (Michigan University), 134-142
  3. Kemenkes RI (2013). Riset Kesehatan Dasar (RIKES-DAS) 2013
  4. Larsen H (2012). Treatment of congestive heart failure. The AFIB Report 1, 4
  5. Longo DL, Kasper DL, Fauci AS, et al (2012). Harrison's principles of internal medicine. 18th ed. New York: McGraw-Hill, p 122–132
  6. Sica DA (2007). Loop diuretic therapy, thiamine balance, and heart failure. Cong Heart Fail (Green-wich, Conn.) 13, 244-247
  7. WHO (2002). Thiamin, riboflavin, niacin, vitamin B6, pantothenic acid and biotin. In: Human Vitamin and Mineral Requirements. Report of a Joint FAO/WHO Expert Consultation. FAO, Rome p 27-30

Most read articles by the same author(s)